See Vivapharm Alginates – Hydrocolloids for Biobased Solutions

The World of Alginates

Introduction

JRS PHARMA‘s Alginate range performs an essential role in a wide variety of healthcare applications. Derived from a rich field of brown seaweed just off the French Brittany coast, the portfolio consists of:

VIVAPHARM® Alginates

• Sodium Alginate
• Calcium Alginate
• Potassium Alginate
• Alginic Acid

Why VIVAPHARM® Alginates?

Due to its viscosifying, gelling as well as film forming and absorption properties under a variety of different conditions, VIVAPHARM® Alginates are one ofx the most versatile hydrocolloids. The ability to dissolve and build up gels without heat and the precise control over the gel setting time by adjusting the crosslinking ion release with sequestrants are key benefits. This versatility is reflected in different applications using alginates, from medical and care to nutraceuticals and pharmaceuticals, such as a thickener in syrups, controlled release in tablets, tablet disintegrant, enteric coating for capsules, wound dressing with hemostatic properties, or a physical raft against reflux.

Quality Made in Europe

JRS, a family-owned, independent company, prioritizes high quality, reliability, and a long-term strategic approach.

The Alginate production takes place at our plants in Landerneau and Lannilis, France. There, the majority of our raw materials, the brown seaweed, is harvested.

• Best-in-class safety practices
• Stringent quality standards
• Environmental protection
• High batch-to-batch consistency

Sustainable Seaweed Harvest

• Supervision of sustainable harvesting practice by public authorities
• Ecologicaly selected harvesting areas and campaign durations
• A short distance from the sea to the production sites for optimal product quality
• Long-term contracts with local fishermen
• Minimal waste production due to application of side products in surrounding agricultures
• Integrated, on-site water purification process

Biobased Hydrocolloid

• No alcohol precipitation
• No limit for acceptable daily intake (ADI) by EFSA and FDA
• Clean label friendly
• Non-animal origin/vegetarian/vegan
• Recognized as GRAS by FDA

JRS VIVAPHARM® Alginates – Manufacturing Process

The extraction technology of Alginic Acid from seaweed is based on more than 50 years of experience at Landerneau and Lannilis.

After extraction, the Alginic Acid is converted into a series of Alginic Acid salts, such as Sodium Alginate. Each type yields ist own unique properties in a wide range of healthcare applications.

Product Overview and Functionalities

With VIVAPHARM® Alginates, JRS PHARMA offers an extensive portfolio for the pharmaceutical, nutraceutical and the medical device market:

• Disintegration and pH-controlled release properties in tablets
• Film forming properties for oxygen protective coatings
• Gel barrier (raft) formation in anti-reflux applications
• Instant gelling for strong, flexible, clear, glossy and uniform film strips, capsules, and 3D scaffolds
• Adsorption and hemostatic behavior in wound care products
• Tailored gelling in dental impressions

VIVAPHARM® Alginates – Product Information Summary

Why VIVAPHARM® Alginates

See the brochure on “Alginates” here

(click the picture to download the brochure)

Source: JRS Pharma, technical brochure “Alginates”

Do you need more information or a sample of JRS Pharma excipients?